Forecasting Biotech on a Budget - Clinical Trials Arena

Go back

Forecasting Biotech on a Budget

Related Content

EKTERLY (sebetralstat) for the Treatment of Hereditary Angioedema, USA

Project

EKTERLY (sebetralstat) for the Treatment of Hereditary Angioedema, USA

IBTROZI (taletrectinib) for the Treatment of Non-small Cell Lung Cancer, USA

Project

IBTROZI for the Treatment of Non-small Cell Lung Cancer, US

Breyanzi (lisocabtagene maraleucel) for the Treatment of Large B-cell lymphoma (LBCL)

Project

Breyanzi for the Treatment of Large B-cell Lymphoma, US

FORZINITY (elamipretide) for Muscle Strength in Barth Syndrome, USA

Project

FORZINITY (elamipretide) for Muscle Strength in Barth syndrome, USA

HERNEXEOS® (zongertinib tablets) for the Treatment of HER-2 Mutant Advanced NSCLC, USA

Project

HERNEXEOS (zongertinib tablets) for the Treatment of HER-2 Mutant Advanced NSCLC, USA

Enhertu

Project

ENHERTU (fam-trastuzumab deruxtecan-nxki) for the treatment of HER2 positive advanced gastric cancer

PALSONIFY (paltusotine)

Project

PALSONIFY (paltusotine) for the Treatment of Acromegaly, USA

COBENFY (xanomeline and trospium chloride) for the Treatment of Schizophrenia, USA

Project

COBENFY for the Treatment of Schizophrenia, US

Project

BALVERSA for the Treatment of Urothelial Carcinoma, US

Iqirvo (elafibranor) for the Treatment of Primary Biliary Cholangitis, USA

Project

Iqirvo for the Treatment of Primary Biliary Cholangitis, US